NCT01005784View on ClinicalTrials.gov

Fixed Versus Flexible Gonadotropin-releasing Hormone (GnRH) Antagonist Initiation

PHASE4CompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

March 31, 2008

Conditions
Subfertility
Interventions
DRUG

Cetrorelix (Cetrotide)

flexible antagonist administration according to specified criteria

DRUG

Cetrorelix (Cetrotide)

fixed antagonist administration on day 6 of ovarian stimulation

Trial Locations (1)

Unknown

Unit for Human Reproduction, Thessaloniki

All Listed Sponsors
lead

Aristotle University Of Thessaloniki

OTHER

NCT01005784 - Fixed Versus Flexible Gonadotropin-releasing Hormone (GnRH) Antagonist Initiation | Biotech Hunter | Biotech Hunter